治疗前预测宫颈癌淋巴结转移的研究进展  

Advances in the Preoperative Prediction of Lymph Node Metastasis in Cervical Cancer

作　　者：王可可 戴文砚 陈倩倩 徐晶晶[1] 王金华[1] WANG Keke;DAI Wenyan;CHEN Qianqian;XU Jingjing;WANG Jinhua(The Affiliated Cancer Hospital of Nanjing Medical University,Jiangsu Cancer Hospital,Jiangsu Institute of Cancer Research,Nanjing 210009,China)

机构地区：[1]南京医科大学附属肿瘤医院,江苏省肿瘤医院,江苏省肿瘤防治研究所,江苏东南京210009

出　　处：《肿瘤学杂志》2023年第7期554-563,共10页Journal of Chinese Oncology

基　　金：中国抗癌协会科研基金(CETSDHRCORP252-3-016)。

摘　　要：淋巴结转移是宫颈癌的主要转移方式之一,淋巴结状态对于早期宫颈癌患者的预后有着重要影响。FIGO2018宫颈癌分期中已将淋巴结状态作为分期标准。目前临床上多以影像学指标对术前淋巴结状态进行评估,其他有效预测指标正在广泛研究中。全文对前哨淋巴结活检、影像学技术、生物标志物、炎症因子等在预测宫颈癌淋巴结转移的研究进展进行综述,为提高治疗前预测淋巴结转移的准确性提供新的方向。Lymph node metastasis is one of the main metastatic modes of cervical cancer,and lymph node status has an important impact on the prognosis of cervical cancer patients,which has been used as a criterion in the FIGO2018 staging of cervical cancer.Currently,preoperative lymph node status is mostly assessed by imaging indices in clinical practice,and other effective predictors are being extensively investigated.This paper reviews the research progress of sentinel lymph node biopsy,imaging techniques and biomarkers in predicting lymph node metastasis of cervical cancer to improve the accuracy of preoperative diagnosis.

关 键 词：宫颈癌 淋巴结转移 前哨淋巴结活检 影像学检查 生物标志物 炎症因子 预测 

分 类 号：R737.33[医药卫生—肿瘤]